Partnerships

A Powerful Engine for Vaccine Creation

How We Work

Here's some things to consider about partnering with us

The POP BIO SNAP platform is ideally suited for the formation of partnerships with industry and academic collaborators. The platform has been well validated through several human clinical trials including the successful completion of Phase 3 clinical studies for COVID-19. The POP BIO SNAP technology is ready for further development in novel targets, with GMP materials readily sourced and prior GLP study data available.

1

Rapidly generate potent nanoparticle vaccine candidates in minutes
Capable of orders-of-magnitude augmentation of humoral and cellular responses

2

Protein-free scaffold with integrated adjuvants

3

Clinically de-risked with COVID-19 (RBD) Ph3 trials meeting primary endpoint

4

Versatile for testing diverse protein/peptide antigens. Also new adjuvants.

5

We can send liposomes to you with instructions to form particles yourselves

6

Seeking new collaborations and areas to apply SNAP
Relations

Development Position

Manufacturing
( Co-PoP & Liposomes)

CoPoP produced under GMP at a 2.5M dose scale.

Toxicology / Pharmacokinetics

GLP toxicity report available.

IND Submission

Clinical validation with EuCorVac-19, SNAP vaccine that completed Phase 3 studies.

Clinical Studies

Currently under clinical translation funded by over $4M in federal funding.

Interested in Working with Us?

Get in Touch!

POP Biotechnologies is located in the Baird Research Park, minutes from the University of Buffalo, North Campus

Office
POP Biotechnologies, Inc.
1576 Sweet Home Road, Suite 221
Buffalo, NY 14228

‍Send Us a Message

Have a question or need assistance? Reach out to us!

Thank you! Your message has been received!
Oops! Something went wrong. Please try again later.